Eurofins Cerep SAS | Small-cap | Healthcare
€18,400.00
0.00%
| Eurofins Cerep SAS Stock Comparison:
Eurofins Cerep SAS vs bioMérieux S.AEurofins Cerep SAS vs Eurofins ScientificEurofins Cerep SAS vs Klea HoldingEurofins Cerep SAS vs Predilife S.AEurofins Cerep SAS vs Lumibird S.AEurofins Cerep SAS vs CAC 40 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 84.1M
Total Liabilities 12.3M
Shareholders Equity 71.7M
Debt to Equity 0.17

Cash Flow Metrics

Revenue & Profitability Trend

Eurofins Cerep SAS Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i40.5M44.1M47.6M41.6M32.7M
Cost of Goods Sold i23.0M23.9M24.0M20.8M16.8M
Gross Profit i17.5M20.2M23.6M20.8M15.8M
Gross Margin % i43.1%45.9%49.6%50.0%48.5%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-----
Other Operating Expenses i919.6K1.7M1.6M1.4M3.3M
Total Operating Expenses i919.6K1.7M1.6M1.4M3.3M
Operating Income i4.7M6.4M11.7M10.1M5.6M
Operating Margin % i11.6%14.6%24.6%24.3%17.3%
Non-Operating Items
Interest Income i292.2K278.5K14.9K02.5K
Interest Expense i07.8K3.2K34.5K16.0K
Other Non-Operating Income-----
Pre-tax Income i6.5M7.1M11.1M9.4M5.1M
Income Tax i-676.1K-516.3K-420.5K-482.6K-431.4K
Effective Tax Rate % i-10.4%-7.2%-3.8%-5.2%-8.4%
Net Income i7.2M7.6M11.5M9.8M5.6M
Net Margin % i17.7%17.3%24.2%23.7%17.1%
Key Metrics
EBITDA i8.6M9.2M12.9M10.9M6.5M
EPS (Basic) i-€1,514.43€2,284.78€1,951.38€1,105.73
EPS (Diluted) i-€1,514.43€2,284.78€1,951.38€1,105.73
Basic Shares Outstanding i-5044504450445044
Diluted Shares Outstanding i-5044504450445044

Income Statement Trend

Eurofins Cerep SAS Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i17.6M8.6M12.8M1.3M4.9M
Short-term Investments i-----
Accounts Receivable i7.9M9.1M8.2M7.1M5.9M
Inventory i3.4M3.8M4.1M2.8M1.9M
Other Current Assets-1----
Total Current Assets i72.7M66.3M58.5M48.3M37.6M
Non-Current Assets
Property, Plant & Equipment i7.5M3.1M3.3M5.4M5.3M
Goodwill i4.7M4.5M4.5M4.5M4.5M
Intangible Assets i202.3K410410410410
Long-term Investments-----
Other Non-Current Assets63.8K153.7K320.3K102.4K324.7K
Total Non-Current Assets i11.4M13.0M12.5M11.4M8.5M
Total Assets i84.1M79.2M71.0M59.7M46.1M
Liabilities
Current Liabilities
Accounts Payable i3.3M3.5M4.6M4.5M3.3M
Short-term Debt i328.5K3.4K3.3K--
Current Portion of Long-term Debt-----
Other Current Liabilities1.6M2.7M3.0M527.5K403.4K
Total Current Liabilities i10.5M12.8M12.3M11.7M8.0M
Non-Current Liabilities
Long-term Debt i001.5K18.9K20.0K
Deferred Tax Liabilities i-----
Other Non-Current Liabilities146.4K48.1K138.0K635.6K635.6K
Total Non-Current Liabilities i1.9M1.8M1.8M2.7M2.9M
Total Liabilities i12.3M14.6M14.1M14.4M10.9M
Equity
Common Stock i75.7K75.7K75.7K75.7K75.7K
Retained Earnings i50.7M43.5M35.9M24.4M20.1M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i71.7M64.6M56.9M45.4M35.1M
Key Metrics
Total Debt i328.5K3.4K4.8K18.9K20.0K
Working Capital i62.2M53.5M46.2M36.6M29.6M

Balance Sheet Composition

Eurofins Cerep SAS Cash Flow Statement

No cash flow data available.

Eurofins Cerep SAS Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 12.97
Price to Sales 2.29

Profitability Ratios

Profit Margin 17.67%
Operating Margin 13.38%
Return on Equity 10.49%
Return on Assets 3.22%

Financial Health

Current Ratio 6.94
Debt to Equity 0.46
Beta 0.47

Per Share Data

EPS (TTM) €1,418.64

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
alecr92.8M12.97-10.49%17.67%0.46
bioMérieux S.A 15.0B35.003.5710.68%10.86%11.65
Eurofins Scientific 12.2B30.013.538.68%6.05%88.06
Klea Holding 64.5M17.872.275.35%8.14%21.13
Predilife S.A 12.3M---4,653.75%97.76%-1.16
Lumibird S.A 400.6M70.002.022.91%2.71%81.34

Financial data is updated regularly. All figures are in the company's reporting currency.